Giant Cell Myocarditis in the New Era of Novel Mechanical Support Systems: A Case Report

Giant Cell Myocarditis in the New Era of Novel Mechanical Support Systems: A Case Report



Maxime Robert-Halabi, Samah Al Kharji, Sebastian-Mihail Georgescu, Renzo Cecere, Nadia Giannetti and Gordan Samoukovic*

McGill University Health Center, Montreal, QC, Canada



Journal of Clinical and Experimental Cardiology



Giant Cell Myocarditis (GCM) is a form of fulminant cardiomyopathy caused by a lymphocytic inflammatory response. Prompt diagnosis, hemodynamic stabilization and initiation of therapy are essential steps in the management of this disease. We report a case of fulminant GCM in which rapid implementation of Venous-Arterial Extracorporeal Membrane oxygenation (VA-ECMO) and subsequent addition of a percutaneous biventricular
mechanical support with an Impella LP 5.0 (Abiomed, Danvers, MA) and a PROTEK Duo (TandemLife, Pittsburgh, PA) while administering immunosuppressants improved the patient clinical status as well biventricular cardiac function. We concluded that the addition of modern percutaneous biventricular supports to VA-ECMO is important to promote cardiac function recovery by offloading the ventricles and we provided a treatment algorithm incorporating
mechanical support in the management of these patients.




Extracorporeal membrane oxygenation; Cardiogenic
shock; Giant cell myocarditis; Heart failure; Immunosuppressive
therapy; Mechanical support device; Ventricular assist device


Read the whole article in the PDF file BELOW


© 2019 Robert-Halabi M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium provided the original author and source are credited.

Fișiere atașate